Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1992 Apr;55(4):328. doi: 10.1136/jnnp.55.4.328

Treatment of Alzheimer's disease.

D M Bowen, P T Francis, A W Procter, A B Young
PMCID: PMC489052  PMID: 1316431

Full text

PDF

Page 328

328

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowen D. M., Francis P. T., Lowe S. L., Pangalos M. N., Procter A. W., Steele J. E. Pyramidal neuron loss and "glycine-site therapy": a need for an animal model and study in late-life depression. Neurobiol Aging. 1989 Sep-Oct;10(5):616–620. doi: 10.1016/0197-4580(89)90152-8. [DOI] [PubMed] [Google Scholar]
  2. Bowen D. M. Treatment of Alzheimer's disease. Molecular pathology versus neurotransmitter-based therapy. Br J Psychiatry. 1990 Sep;157:327–330. doi: 10.1192/bjp.157.3.327. [DOI] [PubMed] [Google Scholar]
  3. Chawluk J. B., Alavi A., Dann R., Hurtig H. I., Bais S., Kushner M. J., Zimmerman R. A., Reivich M. Positron emission tomography in aging and dementia: effect of cerebral atrophy. J Nucl Med. 1987 Apr;28(4):431–437. [PubMed] [Google Scholar]
  4. Chessell I. P., Procter A. W., Francis P. T., Bowen D. M. D-cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-D-aspartate receptor-ionophore complex in Alzheimer brain. Brain Res. 1991 Nov 29;565(2):345–348. doi: 10.1016/0006-8993(91)91668-q. [DOI] [PubMed] [Google Scholar]
  5. Cutler N. R., Haxby J. V., Duara R., Grady C. L., Kay A. D., Kessler R. M., Sundaram M., Rapoport S. I. Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease. Ann Neurol. 1985 Sep;18(3):298–309. doi: 10.1002/ana.410180305. [DOI] [PubMed] [Google Scholar]
  6. DeKosky S. T., Scheff S. W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol. 1990 May;27(5):457–464. doi: 10.1002/ana.410270502. [DOI] [PubMed] [Google Scholar]
  7. Duyckaerts C., Hauw J. J., Piette F., Rainsard C., Poulain V., Berthaux P., Escourolle R. Cortical atrophy in senile dementia of the Alzheimer type is mainly due to a decrease in cortical length. Acta Neuropathol. 1985;66(1):72–74. doi: 10.1007/BF00698298. [DOI] [PubMed] [Google Scholar]
  8. Esiri M. M., Pearson R. C., Steele J. E., Bowen D. M., Powell T. P. A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1990 Feb;53(2):161–165. doi: 10.1136/jnnp.53.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Greenamyre J. T., Young A. B. Excitatory amino acids and Alzheimer's disease. Neurobiol Aging. 1989 Sep-Oct;10(5):593–602. doi: 10.1016/0197-4580(89)90143-7. [DOI] [PubMed] [Google Scholar]
  10. Hood W. F., Compton R. P., Monahan J. B. D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett. 1989 Mar 13;98(1):91–95. doi: 10.1016/0304-3940(89)90379-0. [DOI] [PubMed] [Google Scholar]
  11. Kisvárday Z. F., Martin K. A., Freund T. F., Maglóczky Z., Whitteridge D., Somogyi P. Synaptic targets of HRP-filled layer III pyramidal cells in the cat striate cortex. Exp Brain Res. 1986;64(3):541–552. doi: 10.1007/BF00340492. [DOI] [PubMed] [Google Scholar]
  12. Koh J. Y., Yang L. L., Cotman C. W. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 1990 Nov 19;533(2):315–320. doi: 10.1016/0006-8993(90)91355-k. [DOI] [PubMed] [Google Scholar]
  13. Lange K. W., Wells F. R., Rossor M. N., Jenner P., Marsden C. D. Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease. J Neurol Neurosurg Psychiatry. 1991 Apr;54(4):373–374. doi: 10.1136/jnnp.54.4.373-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Miller J. D., de Leon M. J., Ferris S. H., Kluger A., George A. E., Reisberg B., Sachs H. J., Wolf A. P. Abnormal temporal lobe response in Alzheimer's disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET. J Cereb Blood Flow Metab. 1987 Apr;7(2):248–251. doi: 10.1038/jcbfm.1987.50. [DOI] [PubMed] [Google Scholar]
  15. Monahan J. B., Handelmann G. E., Hood W. F., Cordi A. A. D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. Pharmacol Biochem Behav. 1989 Nov;34(3):649–653. doi: 10.1016/0091-3057(89)90571-6. [DOI] [PubMed] [Google Scholar]
  16. Neary D., Snowden J. S., Mann D. M., Bowen D. M., Sims N. R., Northen B., Yates P. O., Davison A. N. Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry. 1986 Mar;49(3):229–237. doi: 10.1136/jnnp.49.3.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Palmer A. M., Stratmann G. C., Procter A. W., Bowen D. M. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Ann Neurol. 1988 Jun;23(6):616–620. doi: 10.1002/ana.410230616. [DOI] [PubMed] [Google Scholar]
  18. Procter A. W., Stratmann G. C., Francis P. T., Lowe S. L., Bertolucci P. H., Bowen D. M. Characterisation of the glycine modulatory site of the N-methyl-D-aspartate receptor-ionophore complex in human brain. J Neurochem. 1991 Jan;56(1):299–310. doi: 10.1111/j.1471-4159.1991.tb02596.x. [DOI] [PubMed] [Google Scholar]
  19. Swash M., Brooks D. N., Day N. E., Frith C. D., Levy R., Warlow C. P. Clinical trials in Alzheimer's disease. A report from the Medical Research Council Alzheimer's Disease Clinical Trials Committee. J Neurol Neurosurg Psychiatry. 1991 Feb;54(2):178–181. doi: 10.1136/jnnp.54.2.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Watson G. B., Bolanowski M. A., Baganoff M. P., Deppeler C. L., Lanthorn T. H. D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes. Brain Res. 1990 Feb 26;510(1):158–160. doi: 10.1016/0006-8993(90)90745-w. [DOI] [PubMed] [Google Scholar]
  21. Yankner B. A., Caceres A., Duffy L. K. Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc Natl Acad Sci U S A. 1990 Nov;87(22):9020–9023. doi: 10.1073/pnas.87.22.9020. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES